Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis

Siegel, 2023, Cancer statistics, 2023, CA Cancer, J. Clin., 73, 17

Pan, 2020, Next-generation immuno-oncology agents: Current momentum shifts in cancer immunotherapy, J. Hematol. Oncol., 13, 10.1186/s13045-020-00862-w

Weng, 2022, Exploring immunotherapy in colorectal cancer, J. Hematol. Oncol., 15, 10.1186/s13045-022-01294-4

Clay, 2022, Colorectal cancer: The facts in the case of the microbiota, J. Clin. Invest., 132, 10.1172/JCI155101

Gao, 2022, Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites, Gastroenterology, 163, 1024, 10.1053/j.gastro.2022.06.069

Cremonesi, 2018, Gut microbiota modulate T cell trafficking into human colorectal cancer, Gut, 67, 1984, 10.1136/gutjnl-2016-313498

Goc, 2021, Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer, Cell, 184, 5015, 10.1016/j.cell.2021.07.029

Sinha, 2020, Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation, Cell Host Microbe, 27, 659, 10.1016/j.chom.2020.01.021

Pearson, 2019, Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development, Cancer Med, 8, 617, 10.1002/cam4.1965

Chrysostomou, 2023, Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy, Gastroenterology, 164, 198, 10.1053/j.gastro.2022.10.018

Chen, 2023, Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine, Int. J. Biol. Sci., 19, 2097, 10.7150/ijbs.81824

Dong, 2021, Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism, Pharmacol. Res., 171, 10.1016/j.phrs.2021.105767

Messaoudene, 2022, A natural polyphenol exerts antitumor activity and circumvents anti-PD-1 resistance through effects on the gut microbiota, Cancer Discov, 12, 1070, 10.1158/2159-8290.CD-21-0808

Chopra, 2023, Phytochemistry of ginsenosides: Recent advancements and emerging roles, Crit. Rev. Food Sci. Nutr., 63, 613, 10.1080/10408398.2021.1952159

Bai, 2021, Ginsenoside Rk3 alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice, Food Res. Int., 146, 10.1016/j.foodres.2021.110465

Chen, 2021, Ginsenoside Rk3 ameliorates obesity-induced colitis by regulating of intestinal flora and the TLR4/NF-κB signaling pathway in C57BL/6 mice, J. Agric. Food Chem., 69, 3082, 10.1021/acs.jafc.0c07805

Rogers, 2023, Impact of enteric bacterial infections at and beyond the epithelial barrier, Nat. Rev. Microbiol., 21, 260, 10.1038/s41579-022-00794-x

Odenwald, 2017, The intestinal epithelial barrier: A therapeutic target?, Nat. Rev. Gastroenterol. Hepatol., 14, 9, 10.1038/nrgastro.2016.169

Gonçalves, 2016, An intestinal inflammasome – the ILC3-cytokine tango, Trends Mol. Med., 22, 269, 10.1016/j.molmed.2016.02.008

Chun, 2019, Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity, Immunity, 51, 871, 10.1016/j.immuni.2019.09.014

Saeed, 2022, Microbe-based therapies for colorectal cancer: Advantages and limitations, Semin. Cancer Biol., 86, 652, 10.1016/j.semcancer.2021.05.018

Fan, 2021, A. muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs, Cancer Immunol. Res., 9, 1111, 10.1158/2326-6066.CIR-20-1019

Jiang, 2023, Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment, Gut, 72, 1308, 10.1136/gutjnl-2022-327853

Liu, 2022, Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome, Nat. Genet., 54, 52, 10.1038/s41588-021-00968-y

Krautkramer, 2021, Gut microbial metabolites as multi-kingdom intermediates, Nat. Rev. Microbiol., 19, 77, 10.1038/s41579-020-0438-4

Ishak Gabra, 2020, Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth, Nat. Commun., 11, 10.1038/s41467-020-17181-w

Xu, 2022, Protective effects of taurocholic acid on excessive hepatic lipid accumulation via regulation of bile acid metabolism in grouper, Food Funct, 13, 3050, 10.1039/D1FO04085E

Tytgat, 2019, Bowel biofilms: Tipping points between a healthy and compromised gut?, Trends Microbiol, 27, 17, 10.1016/j.tim.2018.08.009

Candelli, 2021, Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases, Int. J. Mol. Sci., 22, 10.3390/ijms22126242

Vilgelm, 2019, Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy, Front. Immunol., 10, 10.3389/fimmu.2019.00333

Bruchard, 2022, Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses, Nat. Immunol., 23, 262, 10.1038/s41590-021-01120-y

Shen, 2021, ILC3 plasticity in microbiome-mediated tumor progression and immunotherapy, Cancer Cell, 39, 1308, 10.1016/j.ccell.2021.08.002

Serafini, 2022, Trained ILC3 responses promote intestinal defense, Science, 375, 859, 10.1126/science.aaz8777

Zheng, 2021, Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism, Cell Metab, 33, 791, 10.1016/j.cmet.2020.11.017

Castellanos, 2020, Innate lymphoid cells link gut microbes with mucosal T cell immunity, Gut Microbes, 11, 231, 10.1080/19490976.2019.1638725

Hepworth, 2013, Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria, Nature, 498, 113, 10.1038/nature12240

Hepworth, 2015, Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells, Science, 348, 1031, 10.1126/science.aaa4812